These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1780377)

  • 1. [Effect of delayed-action Mirenil (Polfa) on the hypothalamic function in patients with schizophrenia].
    Horodnicki JM; Pobocha J
    Psychiatr Pol; 1991; 25(1):7-12. PubMed ID: 1780377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Relations between therapeutic and hormonal response to neuroleptics of patients with paranoid schizophrenia. II. Secretion of prolactin and gonadotropins].
    Horodnicki JM; Jarema M; Warnecka-Przybylska M; Pobocha J; Szakowski A; Drechsler M
    Psychiatr Pol; 1988; 22(4):285-9. PubMed ID: 2907810
    [No Abstract]   [Full Text] [Related]  

  • 3. Experience with fluphenazine decanoate in the management of chronic schizophrenic outpatients.
    Gaby N; Lefkowitz D; Israel JR
    N C Med J; 1982 Sep; 43(9):641-4. PubMed ID: 6958987
    [No Abstract]   [Full Text] [Related]  

  • 4. [Some considerations on the mechanism of action of the hypothalamic hormones which control the secretion of pituitary gonadotropin].
    Jutisz M
    Arch Anat Histol Embryol; 1968; 51(1):363-70. PubMed ID: 4905277
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuroendocrine tests during treatment with neuroleptic drugs. II. The TRH test.
    Braddock LE; Blake IM
    Br J Psychiatry; 1981 Nov; 139():404-7. PubMed ID: 6120732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical neuropharmacology of hypothalamic releasing factors.
    Frohman LA
    N Engl J Med; 1972 Jun; 286(26):1391-7. PubMed ID: 4624031
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative study of the therapeutic effectiveness of mirenil prolongatum and moditen depot in the treatment of schizophrenia].
    Afeltowicz Z; Sep-Kowalikowa B; Zgirski L
    Psychiatr Pol; 1976; 10(5):479-85. PubMed ID: 981421
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of the use of fluphenazine in a depot preparation].
    Marcjan K; Pietruszewska I; Wolak E
    Psychiatr Neurol Med Psychol Beih; 1975; 20-21():176-82. PubMed ID: 829619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Postnatal evolution of hypothalamic releasing factors].
    Scemama A
    J Physiol (Paris); 1972 Oct; 65():Suppl:298A. PubMed ID: 4568019
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypothalamic control of anterior pituitary hormone secretion--characterized hypothalamic-hypophysiotropic peptides.
    Grant GF; Vale W
    Curr Top Exp Endocrinol; 1974; 2():37-72. PubMed ID: 4208407
    [No Abstract]   [Full Text] [Related]  

  • 11. [Characteristics of the therapeutic action fluphenzaine decanoate (moditen-depot) in schizophrenia].
    Tsutsul'kovskaia MIa; Minsker EI; Panteleeva GP; Mazurskii MB; Pekunova LG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(5):753-8. PubMed ID: 4718619
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hypothalamic regulation of anterior pituitary secretion].
    Mornex R; Kressman J; Jordan D
    Rev Prat; 1973 Feb; 23(11):865-76. PubMed ID: 4197355
    [No Abstract]   [Full Text] [Related]  

  • 13. [Neuroendocrine control of prolactin secretion].
    Pasteels JL
    Acta Neurol Psychiatr Belg; 1969 Jul; 69(7):508-17. PubMed ID: 4987515
    [No Abstract]   [Full Text] [Related]  

  • 14. Differential study of 2 long-acting neuroleptics, fluphenazine enanthate and pipothiazine undecylenate.
    Gayral LF; Escande MM; Fournie HC; Huron RJ
    Therapie; 1973; 28(3):611-25. PubMed ID: 4771904
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pituitary gland function test with releasing hormones].
    Kumahara Y; Miyai K; Hashimoto T; Onishi T
    Nihon Rinsho; 1975 Mar; 33(3):572-9. PubMed ID: 805857
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hypothalamic neurohormones and its clinical application].
    Suzuki M; Harano M
    Horumon To Rinsho; 1971 Dec; 19(12):927-34. PubMed ID: 5004352
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of thioridazine and fluphenazine on the pituitary, thyroid and adrenal functions in patients with paranoid schizophrenia.
    Horodnicki JM; Czekalski S; Jarema M
    Psychiatr Pol; 1984; 18(3):205-11. PubMed ID: 6536002
    [No Abstract]   [Full Text] [Related]  

  • 18. Two cases of long term dopamine D2 receptor blockade after depot neuroleptics.
    Harasko-van der Meer C; Brücke T; Wenger S; Fischer P; Deecke L; Podreka I
    J Neural Transm Gen Sect; 1993; 94(3):217-21. PubMed ID: 7907218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuroaminergic control of anterior pituitary secretions (author's transl)].
    Mornex R; Jordan D; Pickering A
    Pathol Biol (Paris); 1976 Oct; 24(8):555-74. PubMed ID: 10544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gonadotropin releasing factor].
    Igarashi M
    Horumon To Rinsho; 1972 Jun; 20(6):427-31. PubMed ID: 4562912
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.